Twist Bioscience (TWST) Cash from Financing Activities (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Cash from Financing Activities data on file, last reported at $4.1 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $4.1 million, up 29.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 million (down 57.23% YoY), and the FY2025 annual result was $28.5 million, up 314.22% from the prior year.
• Cash from Financing Activities rose to $4.1 million in Q1 2026 per TWST's latest filing, from $298000.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $271.6 million in Q1 2022 and troughed at -$1.5 million in Q4 2023.
• A 5-year average of $18.4 million and a median of $1.8 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities soared 18619.23% in 2022, then slumped 272.91% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$395000.0 in 2022, then tumbled by 272.91% to -$1.5 million in 2023, then soared by 1318.19% to $17.9 million in 2024, then tumbled by 98.34% to $298000.0 in 2025, then surged by 1288.59% to $4.1 million in 2026.
• Business Quant data shows TWST's Cash from Financing Activities at $4.1 million in Q1 2026, $298000.0 in Q4 2025, and $5.6 million in Q3 2025.